Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 2, 2007, Pages 400-410

  Duda, Monika ^a   Konior, Anna ^a   Klemenska, Emilia ^a   Beresewicz, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Endothelial dysfunction; Endothelin; Ischemia reperfusion; Ischemic preconditioning; Isolated guinea pig heart; NADPH oxidase; Superoxide; Xanthine oxidase

Indexed keywords

5 HYDROXYDECANOIC ACID; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ALLOPURINOL; APOCYNIN; DIAZOXIDE; ENDOTHELIN 1; OXYGEN; POTASSIUM CHANNEL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; TEZOSENTAN; THENOYLTRIFLUOROACETONE; TUNGSTEN; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DRUG INFUSION; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEEDING; GUINEA PIG; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; ISCHEMIC PRECONDITIONING; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; GUINEA PIGS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NADPH OXIDASE; SUPEROXIDES; XANTHINE OXIDASE;

ANIMALIA; CAVIA;

EID: 33846393614     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.10.014     Document Type: Article

References (48)

1. Grisham M.B., Granger D.N., and Lefer D.J. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radical Biol. Med. 25 (1998) 404-433
2. Zweier J.L. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J. Biol. Chem. 263 (1988) 1353-1357
3. Southworth R., Shattock M.J., Hearse D.J., and Kelly F.J. Developmental differences in superoxide production in isolated guinea-pig hearts during reperfusion. J. Mol. Cell. Cardiol. 30 (1998) 1391-1399
4. - and NO generation in the post-ischemic guinea-pig heart. Cardiovasc. Res. 63 (2004) 118-129
5. Brunner F., du Toit E.F., and Opie L.H. Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J. Mol. Cell. Cardiol. 24 (1992) 1291-1305
6. Velasco C.E., Turner M., Inagami T., Atkinson J.B., Virmani R., Jackson E.K., et al. Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am. Heart J. 128 (1994) 441-451
7. Pernow J., and Wang Q.D. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc. Res. 33 (1997) 518-526
8. Ilebekk A., Aspelin T., Eriksen M., Larsen A., and Lyberg T. Reduced release of vasoconstrictors from the porcine heart after repeated periods of ischemia. Scand. Cardiovasc. J. 39 (2005) 60-66
9. Tsao P.S., Aoki N., Lefer D.J., Johnson G.I., and Lefer A.M. Time-course of endothelial dysfunction and myocardial injury during ischemia and reperfusion in the cat. Circulation 82 (1990) 1402-1412
10. Tsao P.S., and Lefer A.M. Time-course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am. J. Physiol. 259 (1990) H1660-H1666
11. Maczewski M., and Beresewicz A. The role of endothelin, protein kinase C, and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts. J. Mol. Cell. Cardiol. 32 (2000) 297-310
12. Richard V., Kaeffer N., Hogie M., Tron C., Blanc T., and Thuillez C. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Br. J. Pharmacol. 113 (1994) 869-876
13. Li X.S., Wang Q.D., and Pernow J. Beneficial effects of the endothelin antagonist bosentan on myocardial and endothelial injury following ischemia/reperfusion in the rat. Eur. J. Pharmacol. 283 (1995) 161-168
14. Szabo G., Bahrle S., Fazekas L., Macdonald D., Stumpf N., Vahl C.F., et al. Endothelin-A receptor antagonist BQ 123 protects against myocardial and endothelial reperfusion injury. Thorac. Cardiovasc. Surg. 46 (1998) 232-236
15. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
16. Przyklenk K., and Kloner R.A. Ischemic preconditioning: exploring the paradox. Prog. Cardiovasc. Dis. 40 (1998) 517-547
17. DeFily D.V., and Chilian W.M. Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am. J. Physiol. 265 (1993) H700-H706
18. Richard V., Kaeffer N., Tron C., and Thuillez C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 89 (1994) 1254-1261
19. Beresewicz A., Czarnowska E., and Maczewski M. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts. Mol. Cell. Biochem. 186 (1998) 87-92
20. Kharbanda R.K., Peters M., Walton B., Kattenhorn M., Mullen M., Klein N., et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 103 (2001) 1624-1630
21. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
22. Berry C.E., and Hare J.M. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555 (2004) 589-606
23. Duerrschmidt N., Wippich N., Goettsch W., Broemme H.J., and Morawietz H. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem. Biophys. Res. Commun. 269 (2000) 713-717
24. Fei J., Viedt C., Soto U., Elsing C., Jahn L., and Kreuzer J. Endothelin-1 and smooth muscle cells: induction of jun amino-terminal kinase through an oxygen radical-sensitive mechanism. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1244-1249
25. Li L., Fink G.D., Watts S.W., Northcott C.A., Galligan J.J., Pagano P.J., et al. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107 (2003) 1053-1058
26. Touyz R.M., Yao G., Viel E., Amiri F., and Schiffrin E.L. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J. Hypertens. 22 (2004) 1141-1149
27. Callera G.E., Tostes R.C., Yogi A., Montezano A.C., and Touyz R.M. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH oxidase-independent mechanisms. Clin. Sci. 110 (2006) 243-253
28. McNally J.S., Davis M.E., Giddens D.P., Saha A., Hwang J., Dikalov S., et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. 285 (2003) H2290-H2297
29. Kurzelewski M., Czarnowska E., and Beresewicz A. Endothelin in the mechanism of endothelial injury and neutrophil adhesion in the post-ischemic guinea pig heart. Eur. J. Pharmacol. 434 (2002) 95-107
30. Suzuki H., Delano F.A., Parks D.A., Jamshidi N., Granger D.N., Ishii H., et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4754-4759
31. Clozel M., Ramuz H., Clozel J.P., Breu V., Hess P., Loffler B.M., et al. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J. Pharmacol. Exp. Ther. 290 (1999) 840-846
32. Brunner F. Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischaemia and reperfusion. J. Mol. Cell. Cardiol. 27 (1995) 1953-1963
33. Hyland K., Voisin E., Banoun H., and Auclair C. Superoxide dismutase assay using alkaline dimethylsulfoxide as superoxide anion-generating system. Anal. Biochem. 135 (1983) 280-287
34. Ovize M., Przyklenk K., Hale S.L., and Kloner R.A. Preconditioning does not attenuate myocardial stunning. Circulation 85 (1992) 2247-2254
35. Miyamae M., Fujiwara H., Kida M., Yokota R., Tanaka M., Katsuragawa M., et al. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts. Circulation 88 (1993) 223-234
36. Miyamae M., Diamond I., Weiner M.W., Camacho S.A., and Figueredo V.M. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3235-3239
37. Kahler J., Mendel S., Weckmuller J., Orzechowski H.D., Mittmann C., Koster R., et al. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J. Mol. Cell. Cardiol. 32 (2000) 1429-1437
38. Cheng T.H., Shih N.L., Chen S.Y., Wang D.L., and Chen J.J. Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc. Res. 41 (1999) 654-662
39. Tosaki A., Cordis G.A., Szerdahelyi P., Engelman R.M., and Das D.K. Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts. J. Cardiovasc. Pharmacol. 23 (1994) 365-373
40. Van den Hoek T., Becker L.B., Shao Z.H., Li C.Q., and Schumacker P.T. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ. Res. 86 (2000) 541-548
41. 1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J. Mol. Cell. Cardiol. 33 (2001) 121-129
42. McNally J.S., Saxena A., Cai H., Dikalov S., and Harrison D.G. Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1623-1628
43. - production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J. Biol. Chem. 276 (2001) 29251-29256
44. Banes-Berceli A.K., Ogobi S., Tawfik A., Patel B., Shirley A., Pollock D.M., et al. Endothelin-1 activation of JAK2 in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Vascul. Pharmacol. 43 (2005) 310-319
45. Becker L.B., Vandenhoek T.L., Shao Z.H., Li C.Q., and Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol. 277 (1999) H2240-H2246
46. - generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci. 60 (1997) 2207-2219
47. Ushio-Fukai M., Alexander R.W., Akers M., and Griendling K.K. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 273 (1998) 15022-15029
48. Baldus S., Koster R., Chumley P., Heitzer T., Rudolph V., Ostad M.A., et al. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radical Biol. Med. 39 (2005) 1184-1190